Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4 Hydroxycephalexin
2. 4-hydroxycephalexin
3. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(r*)))-
4. Bidocef
5. Bl S 578
6. Bl S578
7. Bl-s 578
8. Bl-s578
9. Bls 578
10. Bls578
11. Cefadroxil
12. Cefadroxil Anhydrous
13. Cephadroxyl
14. Duricef
15. S 578
16. S-578
17. S578
18. Ultracef
1. 66592-87-8
2. Duricef
3. Cefadroxil Hydrate
4. Bidocel
5. Cefadroxil 1-wasser
6. Duracef
7. Mjf 11567-3
8. Bl-s578
9. Cefadroxil (hydrate)
10. (6r,7r)-7-((r)-2-amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid Monohydrate
11. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2r)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, Monohydrate, (6r,7r)-
12. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,7-[[(2r)-amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-,monohydrate, (6r,7r)-
13. Ultracef
14. Moxacef Kapseln
15. Baxan Kapseln
16. Cefos Granulat
17. Kefroxil Kapseln
18. Omnidrox Kapseln
19. Mjf-11567-3
20. 280111g160
21. Cefadroxil (as Monohydrate)
22. (6r,7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Hydrate
23. (6r,7r)-7-[[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
24. Cefadroxil (usp)
25. Duricef (tn)
26. Unii-280111g160
27. Cefadroxil [usan:usp:inn:ban:jan]
28. (6r,7r)-7-[[(2r)-2-azaniumyl-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
29. Cefadroxil [usan]
30. Cefadroxil [vandf]
31. Cefadroxil [usp-rs]
32. Schembl33620
33. Cefadroxil [green Book]
34. Chebi:53667
35. Hy-b1190a
36. Dtxsid80904597
37. Cefadroxil [usp Monograph]
38. Cefadroxil Monohydrate [mi]
39. S3636
40. Cefadroxil Monohydrate [vandf]
41. Akos015896360
42. Ccg-268421
43. Cefadroxil Monohydrate [who-dd]
44. Nsc 756664
45. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, Monohydrate, (6r-(6alpha,7beta(r*)))-
46. As-75209
47. Cefadroxil Monohydrate [ep Monograph]
48. Cs-0014294
49. D02353
50. D95152
51. Q27124149
52. (6r,7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacidhydrate
53. (6r,7r)-7-[(2r)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Hydrate
54. (6r,7r)-7-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid--water (1/1)
55. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, Monohydrate, (6r-(6.alpha.,7.beta.(r*)))
56. 7beta-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic Acid--water (1/1)
| Molecular Weight | 381.4 g/mol |
|---|---|
| Molecular Formula | C16H19N3O6S |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 381.09945651 g/mol |
| Monoisotopic Mass | 381.09945651 g/mol |
| Topological Polar Surface Area | 159 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 629 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
ABOUT THIS PAGE
91
PharmaCompass offers a list of Cefadroxil Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefadroxil Monohydrate manufacturer or Cefadroxil Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefadroxil Monohydrate manufacturer or Cefadroxil Monohydrate supplier.
PharmaCompass also assists you with knowing the Cefadroxil Monohydrate API Price utilized in the formulation of products. Cefadroxil Monohydrate API Price is not always fixed or binding as the Cefadroxil Monohydrate Price is obtained through a variety of data sources. The Cefadroxil Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cefos Granulat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefos Granulat, including repackagers and relabelers. The FDA regulates Cefos Granulat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefos Granulat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cefos Granulat supplier is an individual or a company that provides Cefos Granulat active pharmaceutical ingredient (API) or Cefos Granulat finished formulations upon request. The Cefos Granulat suppliers may include Cefos Granulat API manufacturers, exporters, distributors and traders.
Cefos Granulat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefos Granulat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefos Granulat GMP manufacturer or Cefos Granulat GMP API supplier for your needs.
A Cefos Granulat CoA (Certificate of Analysis) is a formal document that attests to Cefos Granulat's compliance with Cefos Granulat specifications and serves as a tool for batch-level quality control.
Cefos Granulat CoA mostly includes findings from lab analyses of a specific batch. For each Cefos Granulat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefos Granulat may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefos Granulat EP), Cefos Granulat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefos Granulat USP).
